机构:[1]Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, USA.[2]Department of Geriatrics, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, China.[3]Cancer Center, Traditional Chinese Medicine-Integrated Hospital, Southern Medical University, Guangzhou, China.[4]Guangdong Provincial Key Laboratory of Geriatric Infection and Organ Function Support and Guangzhou Key Laboratory of Geriatric Infection and Organ Function Support, Guangzhou, China.[5]Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.[6]Center for Translational Medicine, Guangxi Medical University, Nanning, Guangxi, China.[7]Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, USA.[8]Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, USA.[9]University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, USA.
第一作者机构:[1]Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, USA.[2]Department of Geriatrics, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, China.[3]Cancer Center, Traditional Chinese Medicine-Integrated Hospital, Southern Medical University, Guangzhou, China.[4]Guangdong Provincial Key Laboratory of Geriatric Infection and Organ Function Support and Guangzhou Key Laboratory of Geriatric Infection and Organ Function Support, Guangzhou, China.
推荐引用方式(GB/T 7714):
Yu Xinpei,Ai Junkui,Cai Liquan,et al.Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.[J].Oncotarget.2019,10(67):7181-7182.doi:10.18632/oncotarget.27354.
APA:
Yu Xinpei,Ai Junkui,Cai Liquan,Jing Yifeng,Wang Dan...&Wang Zhou.(2019).Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells..Oncotarget,10,(67)
MLA:
Yu Xinpei,et al."Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.".Oncotarget 10..67(2019):7181-7182